APA (7th ed.) Citation

D, C., X, Z., S, X., & D, L. (2026). Current CMC challenges in oligonucleotide API development: From IND to NDA. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, 35(4), 711. https://doi.org/10.1007/s00044-026-03569-8

Chicago Style (17th ed.) Citation

D, Chen, Zhang X, Xu S, and Liu D. "Current CMC Challenges in Oligonucleotide API Development: From IND to NDA." Medicinal Chemistry Research : An International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents 35, no. 4 (2026): 711. https://doi.org/10.1007/s00044-026-03569-8.

MLA (9th ed.) Citation

D, Chen, et al. "Current CMC Challenges in Oligonucleotide API Development: From IND to NDA." Medicinal Chemistry Research : An International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents, vol. 35, no. 4, 2026, p. 711, https://doi.org/10.1007/s00044-026-03569-8.